These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 2862823

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The value of xamoterol in moderate ischemic cardiac insufficiency].
    Rousseau MF, Cheron P, Vincent MF, Pouleur H, Lavenne F.
    Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Acute effect of the cardioselective beta-1-partial agonist, Corwin, on ventricular function and myocardial oxygen consumption in patients with dilated cardiomyopathy].
    Amende I, Simon R, Hood WP, Lichtlen PR.
    Z Kardiol; 1986 May; 75(5):291-5. PubMed ID: 2874668
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relation of diastolic function and exercise capacity in ischemic left ventricular dysfunction. Role of beta-agonists and beta-antagonists.
    Pouleur H, Hanet C, Rousseau MF, van Eyll C.
    Circulation; 1990 Aug; 82(2 Suppl):I89-96. PubMed ID: 1973644
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failure.
    Marlow HF.
    Circulation; 1990 Feb; 81(2 Suppl):III93-8. PubMed ID: 1967561
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
    Heng MK.
    Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
    [Abstract] [Full Text] [Related]

  • 13. Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease.
    Pouleur H, Etienne J, Van Mechelen H, Van Eyll C, Charlier AA, Brasseur LA, Rousseau MF.
    Postgrad Med J; 1984 Mar; 60 Suppl 4():23-8. PubMed ID: 6527976
    [Abstract] [Full Text] [Related]

  • 14. Effects of a cardioselective beta 1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction.
    Rousseau MF, Pouleur H, Vincent MF.
    Am J Cardiol; 1983 May 01; 51(8):1267-74. PubMed ID: 6133444
    [Abstract] [Full Text] [Related]

  • 15. Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure.
    Holubarsch C, Hasenfuss G, Thierfelder L, Just H.
    Basic Res Cardiol; 1991 May 01; 86 Suppl 1():107-12. PubMed ID: 1827977
    [Abstract] [Full Text] [Related]

  • 16. Left ventricular sensitivity to beta-adrenoceptor-stimulating drugs in patients with ischemic heart disease and varying degrees of ventricular dysfunction.
    Pouleur H, Rousseau MF, Hanet C, Marlow HF, Charlier AA.
    Circ Res; 1987 Oct 01; 61(4 Pt 2):I91-5. PubMed ID: 2820612
    [Abstract] [Full Text] [Related]

  • 17. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB, Schalij MJ, Holman ER, Steendijk P, van der Wall EE, Bax JJ.
    Am J Cardiol; 2006 Jul 15; 98(2):230-5. PubMed ID: 16828599
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of xamoterol on left ventricular diastolic function and late remodeling: a study in patients with anterior myocardial infarction and single-vessel disease.
    Pouleur H, van Eyll C, Hanet C, Cheron P, Charlier AA, Rousseau MF.
    Circulation; 1988 May 15; 77(5):1081-9. PubMed ID: 2896076
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of dobutamine and corwin, a beta 1-adrenergic partial agonist, in experimental left ventricular failure.
    Vik-Mo H, Yasay G, Maroko PR, Ribeiro LG.
    J Cardiovasc Pharmacol; 1985 May 15; 7(4):784-90. PubMed ID: 2410722
    [Abstract] [Full Text] [Related]

  • 20. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B, Holmer SR, Hengstenberg C, Lieb W, Pfeifer M, Schunkert H.
    Int J Cardiol; 2005 Aug 18; 103(2):182-6. PubMed ID: 16080978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.